journal article·2018-11-12Open access

Estimation of radiation dose-reduction factor for cerium oxide nanoparticles in MRC-5 human lung fibroblastic cells and MCF-7 breast-cancer cells

Nouraddin Abdi Goushbolagh, Razzagh Abedi Firouzjah, Kourosh Ebrahimnejad Gorji, Mohammadjavad Khosravanipour, Saman Moradi, Amin Banaei, Akram Astani, Masoud Najafi, Mohammad Hosein Zare, Bagher Farhood

Abstract

In the current study, radiation dose-reduction factor (DRF) of nanoceria or cerium oxide nanoparticles (CONPs) in MRC-5 Human Lung Fibroblastic Cells and MCF-7 Breast-Cancer Cells was estimated. Characterization of CONPs was determined using scanner electron microscope (SEM), energy dispersive spectroscopy (EDS), transmission electron microscopy (TEM) and spectrophotometer. Then, six plans were designed with different radiation dose values on planning target value. The obtained MRC-5 and MCF-7 cells were treated with non-toxic concentrations of CONPs and then exposed. Finally, cell viability (%) of the cell lines was determined using MTT assay. The findings showed that CONPs have no significant radioprotective effect against 10 cGy radiation dose value. Nevertheless, 70 μM CONPs resulted in a significant radioprotection against 100, 200, 300, 400 and 500 cGy radiation dose values compared with the control group in MRC-5 cells. For all radiation dose values, mean cell viability (%) of MCF-7 had not increased significantly at the presence of nanoceria compared with control group. According to the findings, it was revealed that the use of CONPs have a significant radioprotective effect on normal lung cells, while they do not provide any protection for MCF-7 cancer cells. These properties can help to increase therapeutic ratio of radiotherapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Medical Physics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences

Department of Medical Physics Radiobiology and Radiation Protection, Babol University of Medical Sciences

Department of Medical Physics, Faculty of Medical Sciences, Tarbiat Modares University

Zoonotic Diseases Research Center, School of public health, Shahid Sadoughi University of Medical Sciences

Department of Microbiology, Faculty of Medical sciences, Shahid Sadoughi University of Medical Sciences

Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Sciences

Radiotherapy Research Center, Shahid Sadoughi University of Medical Sciences

Departments of Medical Physics and Radiology, Faculty of Paramedical Sciences, Kashan University of Medical Sciences

References (37)

Show source-provided references
1. Farhood B, Geraily G, Alizadeh A. Incidence and mortality of various cancers in Iran and compare to other countries: a review article. Iran J Public Health. 2018;47:309–316.
2. 10.1007/s12094-017-1828-610.1007/s12094-017-1828-6 ↗
3. 10.4103/0973-1482.17642310.4103/0973-1482.176423 ↗
4. 10.7150/ijms.363510.7150/ijms.3635 ↗
5. 10.3390/ijerph912474410.3390/ijerph9124744 ↗
6. Supramaniam R. New malignancies among cancer survivors: SEER cancer registries, 1973–2000. J Epidemiol Community Health. 2008;62:375–376.
7. 10.1016/j.radonc.2010.01.01110.1016/j.radonc.2010.01.011 ↗
8. 10.1002/978111934115410.1002/9781119341154 ↗
9. Khan FM, Gibbons JP. Khan's the Physics of Radiation Therapy. Philadelphia: Lippincott Williams & Wilkins; 2014.
10. 10.1177/175628721037446210.1177/1756287210374462 ↗
11. 10.5455/2319-2003.ijbcp2013120310.5455/2319-2003.ijbcp20131203 ↗
12. 10.1007/s12079-018-0473-310.1007/s12079-018-0473-3 ↗
13. 10.1080/09553002.2018.144009210.1080/09553002.2018.1440092 ↗
14. 10.2174/187446721166618061912565310.2174/1874467211666180619125653 ↗
15. 10.1124/jpet.111.17997810.1124/jpet.111.179978 ↗
16. 10.1016/j.cbi.2015.03.01310.1016/j.cbi.2015.03.013 ↗
17. Baker CH. Harnessing cerium oxide nanoparticles to protect normal tissue from radiation damage. Transl Cancer Res. 2013;2:343–358.
18. 10.1016/j.radonc.2014.10.00410.1016/j.radonc.2014.10.004 ↗
19. Valentin J. The 2007 Recommendations of the International Commission on Radiological Protection. Amsterdam: Elsevier Oxford; 2007.
20. 10.1016/j.jcin.2014.12.23310.1016/j.jcin.2014.12.233 ↗
21. Hall EJ, Giaccia AJ. Radiobiology for the Radiologist. Philadelphia: Lippincott Williams & Wilkins; 2006.
22. Nadi S, Monfared AS, Mozdarani H, et al. Effects of arbutin on radiation-induced micronuclei in mice bone marrow cells and its definite dose reduction factor. Iran J Med Sci. 2016;41:180–185.
23. 10.1006/jcis.2001.804710.1006/jcis.2001.8047 ↗
24. 10.1016/j.jcis.2011.01.06310.1016/j.jcis.2011.01.063 ↗
25. 10.1080/1091581060095954310.1080/10915810600959543 ↗
26. 10.1016/j.tox.2007.12.02210.1016/j.tox.2007.12.022 ↗
27. 10.1007/s00204-015-1468-y10.1007/s00204-015-1468-y ↗
28. 10.1016/j.wasman.2009.04.00110.1016/j.wasman.2009.04.001 ↗
29. 10.1016/j.nano.2010.01.01010.1016/j.nano.2010.01.010 ↗
30. 10.1016/j.ejmp.2016.03.01410.1016/j.ejmp.2016.03.014 ↗
31. 10.1007/s12668-018-0538-z10.1007/s12668-018-0538-z ↗
32. 10.1039/C6RA18566E10.1039/C6RA18566E ↗
33. 10.1021/nl052024f10.1021/nl052024f ↗
34. 10.1016/j.nano.2013.02.00810.1016/j.nano.2013.02.008 ↗
35. 10.1016/j.nano.2008.10.00310.1016/j.nano.2008.10.003 ↗
36. Khan FM, Gerbi BJ. Treatment Planning in Radiation Oncology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2012.
37. 10.1016/0360-3016(91)90171-Y10.1016/0360-3016(91)90171-Y ↗